Self-care in Europe
This article was originally published in The Tan Sheet
Self-managing health care is becoming increasingly acceptable in Europe, Hubertus Cranz, PhD, director general of the Association of the European Self-Medication Industry (AESGP) said during CHPA's Regulatory & Scientific Conference in Washington, D.C. May 2. "Ten, 15 years ago it would have been impossible to even talk about a patient self-managing health care," he explained, describing the European setting as "much more restrictive" than that in the U.S. or UK. Progress has since been made, Cranz said, pointing out that from 2001 to 2002 the Standing Committee of European Doctors participated in AESGP's study on new indications for self-medication. In 2006, the AESGP was involved in a joint project with the World Medical Association entitled, "From Patient to Self-Health Manager." Cranz credited the UK for setting the example, explaining that the "UK government policy is to encourage self-care"...
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.